Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Delphic Diagnostics was a UK-based healthcare company established in 2020 to provide rapid and reliable diagnostic testing services during the COVID-19 pandemic. The company specialized in high-throughput PCR testing, lateral flow assays, and antibody screening, serving sectors such as international travel, corporate offices, and the entertainment industry. Delphic Diagnostics integrated laboratory logistics with digital health platforms to provide seamless testing and certification workflows. They operated as an approved private provider for the UK government's mandatory travel testing schemes. Although it was a key player in the UK's private diagnostic market for several years, the company was officially dissolved in November 2023.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Delphic Diagnostics.